Report Categories
View AllRecent Articles
View All
Why SmartStop SMA Just Surged 094 Key Levels Ahead 20260518
CantorEquity CEPT Declines 181 Amid Market Weakness 20260515
Duke Energy DUKB Q1 2026 Earnings EPS 193 Beats Estimates
Galata LATA Stock Steady at 1005 Support at 955 20260518
Ford Motor F Q1 2026 Earnings EPS 066 Beats Estimates
Chiron XRN Q1 2026 Results Disappoint What Investors Should Know
Star Bulk SBLK Reports Strong Q4 2025 Revenue NA EPS Beats
April Jobs Report Preview Modest Growth Expected Amid Cooling Labor Market
Duke Energy DUK Faces 5 Price Target Adjustment Amid Market Scrutiny
UK Government Urged to Proceed with ZeroHours Contract Ban Despite Business Opposition
US Iran Signal Progress on Middle East Peace But Remain Divided Over Uranium Enrichment and Strait of Hormuz Tolls
Lenovo Shares Surge on Record Earnings as AI Revenue Nearly Doubles
Rising Gas Prices Drive Interest in FuelEfficient Trucks Ford Maverick Hybrid and Ram 1500 Lead the Way
AI Industry Emerges as Key Beneficiary of HighProfile MuskAltman Legal Proceedings
TRTX Q1 2026 Earnings EPS Slightly Misses Estimates Stock Rises 073
AAOI Q1 2026 Earnings EPS Misses Estimates as Stock Rises Despite Wider Loss
JLL Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Uncertainty
NNOX Q4 2025 Earnings WiderThanExpected Loss as Revenue Details Remain Scarce
Vishay Intertechnology Q1 2026 Earnings EPS Surprises to the Upside Amid Revenue Disclosure Absence
Polibeli Group Ltd PLBL Holds Steady at 71 as Market Waits for Catalyst
Personalis Inc PSNL Rallies 615 Testing Key Resistance Near 10
ProCap Financial Warrants BRRWW Consolidate at 021 as Price Action Remains RangeBound
Brookfield Infrastructure Preferred Shares BIPJ Slip Slightly as YieldSeeking Investors Weigh Market Dynamics
Unity Software U Stock Market Sentiment 818 20260415
Market Pulse Tech leads gains as consumer sector lags in steady trading
CBIO Crescent Bio jumps 4 as Q1 loss beats estimates by 27 pipeline progress lifts investor confidence
ENTX Entera Bio Ltd Ordinary Shares rises 442 percent on Q4 2025 EPS beat despite sharp year over year revenue decline
Is Palvella Therapeutics PVLA a value trap or a value play 1299 20260507
Taiwan TWN Stock Entry Strategy 219 20260416